Blockchain Registration Transaction Record

Beam Therapeutics to Present BEAM-101 Trial Data at EHA Congress 2025

Beam Therapeutics announces presentation of BEAM-101 trial data at EHA Congress 2025, highlighting the therapy's potential to provide a durable treatment for sickle cell disease. The focus on precision genetic medicines through base editing could revolutionize treatment approaches for genetic disorders.

Beam Therapeutics to Present BEAM-101 Trial Data at EHA Congress 2025

This news matters as it showcases the potential of BEAM-101 to provide a durable treatment for sickle cell disease by presenting updated data at a prestigious medical congress. The therapy's focus on precision genetic medicines through base editing could revolutionize treatment approaches for SCD and other genetic disorders.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x272b5ebd063705d99cb86d25457e53fc9d43b3cf9b1f8c0c9341f2dfd681dd92
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintcakeWtb9-63f6917c609ac1080509ad64a7985b73